Pharmaceutical Technology6 小时
SMART-101 by Smart Immune for Relapsed Acute Myeloid Leukemia: Likelihood of Approval
SMART-101 is under clinical development by Smart Immune and currently in Phase II for Relapsed Acute Myeloid Leukemia.
Pharmaceutical Technology6 小时
SMART-101 by Smart Immune for Refractory Acute Myeloid Leukemia: Likelihood of Approval
SMART-101 is under clinical development by Smart Immune and currently in Phase II for Refractory Acute Myeloid Leukemia.
'I went on a first date with my work crush only to find out I had cancer on the same day'
Two colleagues who were crushing on each other for months finally set up first date - only to find out that evening that one ...